BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature related to cancer diagnosis. The discovery is being patented.
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
BioMark Diagnostics and Principal Investigators Publish an Important Approach Using Metabolomics and ML to Identify
BioMark Diagnostics Completes Testing of Over 5,400 subjects as Part of a Validation Study for
Biomark Diagnostics to Showcase Innovative Liquid Biopsy Technology at H.C. Wainwright’s 26th Annual Global Investment
Form 7 Monthly Progress Report Sept 2024 Name of Listed Issuer: Trading Symbol: Number of
Form 7 Monthly Progress Report July 2024 Name of Listed Issuer: Trading Symbol: Number of
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2